| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Director | Director, 10% Owner
3 companies
Bolzon Bradley J Phd is a Director, 10% Owner at GLUE, with reported holdings spanning 3 companies. Recent filings cover 9 purchases and 194 sales. Those positions are worth an estimated $59.0M at current prices.
Our model assigns Bolzon Bradley J Phd a strong insider score of 75/100, based on 6 past trades. Over a 12-month horizon, 83.3% of those trades were profitable, with an average 12-month return of +33.1%.
Bolzon Bradley J Phd's largest disclosed position is in GLUE as Director, 10% Owner, worth about $39.9M. Net of sales, the recent Form 4 record there shows accumulation of 157,895 shares.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Jun 23, 2020 | CRSP Crispr Therapeutics AG | Director | Sell | 20,000 | $73.93 | $1,478,522.00 | -3.4% | |
| Feb 3, 2020 | BDTX Black Diamond Therapeutics, Inc. | Director | Buy | 894,736 | $19.00 | $16,999,984.00 | +286.9% | |
| Nov 19, 2019 | CRSP Crispr Therapeutics AG | Director | Sell | 42,000 | $67.41 | $2,831,388.00 | -6.6% | |
| Oct 30, 2019 | CRSP Crispr Therapeutics AG | Director | Sell | 21,000 | $51.89 | $1,089,675.30 | -60.4% | |
| May 15, 2018 | CRSP Crispr Therapeutics AG | Director | Sell | 44,000 | $57.99 | $2,551,440.00 | -6.4% | |
| May 8, 2018 | CRSP Crispr Therapeutics AG | Director | Sell | 128,950 | $50.39 | $6,497,892.30 | -78.8% | |
| Apr 30, 2018 | CRSP Crispr Therapeutics AG | Director | Sell | 30,566 | $50.29 | $1,537,137.92 | -23.6% | |
| Apr 27, 2018 | CRSP Crispr Therapeutics AG | Director | Sell | 222,258 | $50.11 | $11,136,437.01 | -68.8% | |
| Apr 24, 2018 | CRSP Crispr Therapeutics AG | Director | Sell | 22,841 | $50.99 | $1,164,655.40 | -16.5% | |
| Apr 23, 2018 | CRSP Crispr Therapeutics AG | Director | Sell | 101,994 | $50.68 | $5,168,901.34 | -46.5% |